Back to Search
Start Over
Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
- Source :
-
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception [Eur J Contracept Reprod Health Care] 2020 Dec; Vol. 25 (6), pp. 492-501. - Publication Year :
- 2020
-
Abstract
- Objective: Half of all pregnancies worldwide are unintended, and the rate is even higher in women aged ≤25 years. We sought to identify which method of contraception was the most effective option to prevent unintended pregnancy in young women and adolescents.<br />Methods: Systematic searches, without language restrictions, were carried out of the PubMed, Embase, Lilacs and Cochrane databases from inception to July 2020. Abstracts and full-text articles of observational studies and randomised controlled trials comparing the use of multiple methods of long-acting reversible contraception (LARC) and short-acting reversible contraception (SARC) in young women and adolescents were screened and reviewed. Risk ratios (RRs) and mean differences with their 95% confidence interval (CI) were derived using a random-effects meta-analytical model. Meta-analyses provided pooled estimates for adverse events, continuation rates and efficacy of LARC methods in young women and adolescents. Nine of the 25 included studies compared LARC with SARC, and 16 compared LARC methods only.<br />Results: At 12 months, young women had better adherence with LARC compared with SARC ( n = 1606; RR 1.60; 95% CI 1.21, 2.12; I <superscript>2</superscript> = 88%), which suggests a better unintended pregnancy prevention outcome for young women. However, more young women chose SARC ( n = 2835; RR 0.37; 95% CI 0.17, 0.80; I <superscript>2</superscript> = 99%). Pregnancy during LARC use was rare.<br />Conclusion: LARC methods are the most efficacious in preventing pregnancy, and women should be informed of this if pregnancy prevention is their priority. The evidence, however, is of low quality.<br />Prospero Registration Number: CRD42017055452.
- Subjects :
- Adolescent
Contraceptive Agents, Female pharmacology
Female
Humans
Intrauterine Devices, Medicated
Long-Acting Reversible Contraception statistics & numerical data
Pregnancy
Pregnancy, Unplanned
Young Adult
Contraception methods
Contraception statistics & numerical data
Contraceptive Agents, Female therapeutic use
Medication Adherence statistics & numerical data
Subjects
Details
- Language :
- English
- ISSN :
- 1473-0782
- Volume :
- 25
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
- Publication Type :
- Academic Journal
- Accession number :
- 33140990
- Full Text :
- https://doi.org/10.1080/13625187.2020.1833187